This AudioEducate activity, available through the Alexa app, is comprised of an expert commentary interview that highlights the most pertinent & relevant content from the "Dyslipidemia/Atherosclerosis" session at 2018 CMHC West meeting.
Christie Ballantyne, MD and Marc Sabatine, MD—two leading experts in the field of cardiometabolic health—discuss the PCSK9 inhibitor cardiovascular outcomes trials, FOURIER, and ODYSSEY outcomes, and the relevance to treatment of ASCVD in the everyday clinical setting. The interview additionally explores the efficacy and safety of PCSK9 inhibitors: specifically, the safety of very low LDL-C. Dr. Ballantyne and Dr. Sabatine examine the future of LDL-C reduction in patients with high risk of ASCVD through a discussion surrounding emerging agents. This audio educational activity is designed to equip healthcare providers with the necessary knowledge to address the clinical challenges in non-statin drugs, and navigate newly emerging approaches.
Activity Title: 2018 CMHC West Expert Interview: Non-Statin Drugs and New Approaches
Activity Format: Enduring, Audio and Audience Response
This educational activity is comprised of an expert commentary interview that highlights the most pertinent content from the Dyslipidemia/Atherosclerosis Session at 2018 CMHC West meeting. Christie Ballantyne, MD and Marc Sabatine, MD, two leading experts in the field, discuss the PCSK9 inhibitor cardiovascular outcomes trials, FOURIER and ODYSSEY Outcomes, and the relevance to treatment of ASCVD in the every day clinical setting. During the module, the efficacy and safety of PCSK9 inhibitors, particularly the safety of very low LDL-C is also discussed. Concluding the module, Dr. Ballantyne and Dr. Sabatine examine the future of LDL-C reduction in patients with high risk of ASCVD with a discussion on emerging agents. Overall, this module will equip health care providers with the knowledge necessary to address the clinical challenges in non-statin drugs and new approaches. Downloadable transcripts and slides will also be provided to the learner.
Estimated Time to Complete: 0.5 hr
Release Date: 11/29/2018
Expiration Date: 11/29/2019
Credit Type(s) Available: ACCME, CDR, ACPE, ANCC
Maximum Credits: 0.5
This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.
This activity is supported by educational funding provided by Amgen.
US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals.
Upon completion of this activity, participants should be able to:
Christie M. Ballantyne, MD (Chair)
Grant/Research Support (all significant, all paid to institution, not individual): Abbott Diagnostic, Amarin, Amgen, Esperion, lonis, Novartis, Pfizer, Regeneron, Roche Diagnostic, SanofiSynthelabo, NIH, AHA, ADA.
Consultant/Independent Contractor: Abbott Diagnostics, Amarin, Amgen, AstraZeneca*, Boehringer lngelheim*, Eli Lilly, Esperion, lonis, Matinas BioPharma Inc, Merck*, Novartis, Pfizer*, Regeneron, Roche Diagnostic, Sanofi-Synthelabo*
*Significant where noted (>$10,000); remainder modest (<$10,000).
Marc S. Sabatine, MD, MPH
Grant/Research Support: Amgen; AstraZeneca; Daiichi-Sankyo; Eisai; GlaxoSmithKline; Intarcia; Janssen Research and Development; Medicines Company; MedImmune; Merck; Novartis; Pfizer; Poxel; Takeda
Consultant/Independent Contractor: Amgen; Bristol-Myers Squibb; CVS Caremark; Esperion; Ionis; Intarcia; Janssen Research and Development; MedImmune; Merck; Novartis (all ≤$10,000 per year except Amgen and Esperion)
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Amanda Turner has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Karin McAdams has nothing to disclose.
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
Global Education Group designates this virtual activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This educational activity for 0.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Accreditation Statement
Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global Education Group designates this continuing education activity for 0.5 contact hour(s) (0.05 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Universal Activity Number (UAN): 0530-9999-18-376-H01-P
Dietician Accreditation Statement
Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 0.5 Continuing Professional Education units (CPEUs) for completion of this activities / materials.
CPE Provider #GE012
For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or email@example.com
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This activity is offered at no cost to participants. During the period 11/29/2018, through 11/29/2019, participants must listen to the full audio and successfully complete the interactive audio exam and evaluation portion in order to receive CME/CE credit:
Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6-10 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.